Highlights of IAGG 2026 [0.03%]
IAGG 2026大会亮点
Philippa K Harris
Philippa K Harris
Deprescribing trials need a rationale-first framework before choosing trial design [0.03%]
降药化治疗试验需要在选择试验设计之前首先确定试验的合理性框架
Lorenz Roger Van der Linden
Lorenz Roger Van der Linden
Deprescribing trials need a rationale-first framework before choosing trial design [0.03%]
降药化药物治疗试验需要在选择试验设计之前先确立合理的框架
Catherine S Hwang,Kenneth S Boockvar,Michael A Steinman
Catherine S Hwang
Effectiveness of dyadic interventions in improving outcomes for adults with multiple long-term conditions or frailty and their informal carers: a systematic review [0.03%]
改善成人多重慢性病或衰弱患者及其照顾者结局的双元干预效果：系统综述
Stella Arakelyan,Daniela Lillekroken,Mozhu Ding et al.
Stella Arakelyan et al.
Dyadic interventions targeting carer-care recipient pairs are effective in improving psychosocial outcomes in single diseases, but whether similar interventions are beneficial in the context of multiple long-term conditions or frailty remai...
Frailty, clinical outcomes, and treatment effects of a care bundle in acute intracerebral haemorrhage: a post-hoc analysis of the INTERACT3 trial [0.03%]
脆弱性、临床结局和急性脑出血患者护理包的治疗效果：INTERACT3试验的事后分析
Tao Liu,Linan Chen,Yang Liu et al.
Tao Liu et al.
Background: Frailty has been widely associated with poor outcomes in mixed stroke cohorts, but evidence specific to intracerebral haemorrhage, particularly from settings in low-income and middle-income countries and regar...
Incidence of dementia after age 90 years and association with APOE genotype, race, and sex in the USA: the LifeAfter90 prospective cohort study [0.03%]
美国90岁以后的痴呆发病率及其与APOE基因型、种族和性别的关联：LifeAfter90前瞻性队列研究
Hilary L Colbeth,Maria M Corrada,Dan Mungas et al.
Hilary L Colbeth et al.
Background: Little is known about dementia incidence and its risk factors in people older than 90 years, particularly in heterogeneous populations. We evaluated dementia incidence and examined the associations of sex, rac...
Adjunctive metformin for obesity and frailty in older people-puncturing inflated expectations? [0.03%]
辅助二甲双胍治疗老年人肥胖和衰弱问题——戳破过高的期望？
Miles D Witham,Claire McDonald
Miles D Witham
Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial [0.03%]
二甲双胍联合生活方式干预改善肥胖老年人身体功能的疗效研究（DEMFOS试验）：一项随机对照试验
Maria Liza Duremdes Nava,Viola Viola,Marlene Aguilar et al.
Maria Liza Duremdes Nava et al.
Background: Obesity in older adults is associated with functional decline and increased risk of disability. Lifestyle interventions improve physical function, but the role of metformin as an adjunct to lifestyle intervent...
Falls resilience framework: advancing from risk reduction to resilience building in older adults [0.03%]
老年人防跌倒韧性框架：从风险降低到增强韧性的进步
Deepak K Ravi,Jeffrey M Hausdorff,Heather E Whitson et al.
Deepak K Ravi et al.
Despite extensive research and public health initiatives, progress in reducing the global burden of falls among older adults has remained slow, underscoring the need for complementary frameworks to guide prevention and management. We propos...
Giancarlo Icardi,Vincenzo Paolozzi
Giancarlo Icardi